- Corporate Officers - A
- Almenoff June Sherie
Insider Trading History of Almenoff June Sherie
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Almenoff June Sherie since 2011.
This trader's CIK number is 1492647.
At the time of last reporting, Almenoff June Sherie was the Director of Avalo Therapeutics, Inc.. (stock ticker symbol AVTX).
Also see all insider trading activities at Avalo Therapeutics, Inc..
Note that in the past
Almenoff June Sherie also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at 9 Meters Biopharma, Inc. (INNT) by Almenoff June Sherie
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | INNT | 1,400 | $6,870 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Avalo Therapeutics, Inc. (AVTX) by Almenoff June Sherie
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | AVTX | 0 | $0 | 0 | $0 | 3,167 | $0 |
| 2024 | AVTX | 1,000 | $12,749 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Brainstorm Cell Therapeutics Inc. (BCLI) by Almenoff June Sherie
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | BCLI | 1,475 | $5,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Furiex Pharmaceuticals, Inc. (FURX) by Almenoff June Sherie
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | FURX | 0 | $0 | 115,113 | $13,402,031 | 115,113 | $1,477,590 |
| 2012 | FURX | 3,000 | $48,273 | 0 | $0 | 0 | $0 |
| 2011 | FURX | 1,000 | $14,950 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Neubase Therapeutics, Inc. (OHRP) by Almenoff June Sherie
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | OHRP | 6,000 | $40,500 | 0 | $0 | 0 | $0 |
| 2014 | OHRP | 10,900 | $100,842 | 0 | $0 | 0 | $0 |
Insider trading activities at 5 companies by Almenoff June Sherie:
1. 9 Meters Biopharma, Inc. (INNT)
2. Avalo Therapeutics, Inc. (AVTX)
3. Brainstorm Cell Therapeutics Inc. (BCLI)
4. Furiex Pharmaceuticals, Inc. (FURX)
5. Neubase Therapeutics, Inc. (OHRP)
Table 1. Insider trading of 9 Meters Biopharma, Inc. (INNT) by Almenoff June Sherie
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-08-24 | INNT | Buy | 1,000 | 4.90 | 4,897 |
| 2018-08-27 | INNT | Buy | 400 | 4.93 | 1,973 |
Table 2. Insider trading of Avalo Therapeutics, Inc. (AVTX) by Almenoff June Sherie
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-03-28 | AVTX | Option Ex | 3,167 | .00 | 0 |
| 2024-11-12 | AVTX | Buy | 500 | 12.50 | 6,249 |
| 2024-11-13 | AVTX | Buy | 500 | 13.00 | 6,500 |
Table 3. Insider trading of Brainstorm Cell Therapeutics Inc. (BCLI) by Almenoff June Sherie
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-01-04 | BCLI | Buy | 1,475 | 3.39 | 5,000 |
Table 4. Insider trading of Furiex Pharmaceuticals, Inc. (FURX) by Almenoff June Sherie
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-02-04 | FURX | Option Ex | 115,113 | 12.84 | 1,477,590 |
| 2014-02-04 | FURX | Sale | 115,113 | 116.42 | 13,402,031 |
| 2012-08-14 | FURX | Buy | 50 | 18.55 | 927 |
| 2012-08-15 | FURX | Buy | 950 | 18.68 | 17,746 |
| 2012-05-17 | FURX | Buy | 2,000 | 14.80 | 29,600 |
| 2011-09-09 | FURX | Buy | 1,000 | 14.95 | 14,950 |
Table 5. Insider trading of Neubase Therapeutics, Inc. (OHRP) by Almenoff June Sherie
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-02-06 | OHRP | Buy | 6,000 | 6.75 | 40,500 |
| 2014-09-02 | OHRP | Buy | 1,000 | 8.12 | 8,119 |
| 2014-09-03 | OHRP | Buy | 1,200 | 8.05 | 9,660 |
| 2014-06-26 | OHRP | Buy | 3,200 | 8.34 | 26,688 |
| 2014-04-08 | OHRP | Buy | 5,500 | 10.25 | 56,375 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Almenoff June Sherie
(Director of Avalo Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.